Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Homozygous Sitosterolemia”

8 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 8 of 8 results

Large-scale testing (Phase 3)Study completedNCT00092807
What this trial is testing

Sitosterolemia Extension Study (0653-003)(COMPLETED)

Who this might be right for
Lipid Metabolism, Inborn ErrorsHeart Disease
Organon and Co 37
Large-scale testing (Phase 3)Study completedNCT00092820
What this trial is testing

Sitosterolemia Extension Study (0653-004)(COMPLETED)

Who this might be right for
Lipid Metabolism, Inborn ErrorsHeart Disease
Organon and Co 58
Large-scale testing (Phase 3)Study completedNCT00092898
What this trial is testing

An Investigational Drug Study to Lower Non-Cholesterol Sterol Levels Associated With Sitosterolemia (0653-062)(COMPLETED)

Who this might be right for
Lipid Metabolism, Inborn ErrorsHeart Disease
Organon and Co 30
Large-scale testing (Phase 3)Study completedNCT00099996
What this trial is testing

Higher-Dose Ezetimibe to Treat Homozygous Sitosterolemia

Who this might be right for
Heart DiseasesMetabolism, Inborn Errors
National Heart, Lung, and Blood Institute (NHLBI) 3
Large-scale testing (Phase 3)Ended earlyNCT00092833
What this trial is testing

Investigational Drug in Patients With Hypercholesterolemia or in Patients With Sitosterolemia (0653-026)(COMPLETED)

Who this might be right for
Hypercholesterolemia, FamilialLipid Metabolism, Inborn Errors
Organon and Co 49
Not applicableStudy completedNCT00705211
What this trial is testing

A 52-week Post-marketing, Observational Study to Confirm the Safety and Efficacy of Zetia Alone or in Combination With Other Lipid-lowering Drugs in Japanese Subjects With Hypercholesterolemia (Study P05245)

Who this might be right for
HypercholesterolemiaFamilial HypercholesterolemiaHomozygous Sitosterolemia
Organon and Co 1,794
Testing effectiveness (Phase 2)Study completedNCT00045812
What this trial is testing

SCH-58235 (Ezetimibe) to Treat Homozygous Sitosterolemia

Who this might be right for
Lipoidosis
National Heart, Lung, and Blood Institute (NHLBI) 5
Not applicableStudy completedNCT00704444
What this trial is testing

A 12-week Post-marketing, Observational Study to Confirm the Safety and Efficacy of Zetia Alone or in Combination With Other Lipid-lowering Drugs in Japanese Subjects With Hypercholesterolemia (Study P05244)

Who this might be right for
HypercholesterolemiaFamilial HypercholesterolemiaHomozygous Sitosterolemia
Organon and Co 11,332